Currently, the only drugs available to Alzheimer’s patients are ones that delay symptoms. But aducanumab promises to alter the course of the disease.
↧
Currently, the only drugs available to Alzheimer’s patients are ones that delay symptoms. But aducanumab promises to alter the course of the disease.